O'Kane, Grainne M <br/><br/>
The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  05 2019 
 - 86-89 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2019.03.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acrylamides--therapeutic use<br/>Alleles<br/>Aniline Compounds--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Circulating Tumor DNA--genetics<br/>Disease Progression<br/>Drug Resistance, Neoplasm--genetics<br/>ErbB Receptors--genetics<br/>Female<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mutation--genetics<br/>Neoplasm Staging<br/>Polymorphism, Genetic<br/>Prospective Studies<br/>Protein Kinase Inhibitors--therapeutic use